Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Clin Res Pediatr Endocrinol ; 15(2): 145-153, 2023 05 29.
Article in English | MEDLINE | ID: mdl-36597761

ABSTRACT

Objective: This study was planned to determine the effects of carob use on puberty because of the observation of early puberty or pubertal variants due to the long-term use of carob in our clinic. Methods: Forty-eight Wistar albino rats, on postnatal day 21, were assigned into two groups female (n=24) and male (n=24). Groups were divided into four groups Control, and Carob-150, Carob-300, and Carob-600. Ceratonia siliqua L. extract was given to rats in a 0.5% carboxymethylcellulose (CMC) solution. CMC (0.5%) was given to the control, Ceratonia siliqua L. extract was given 150 mg/kg/day to the Carob-150, 300 mg/kg/day to the Carob-300, 600 mg/kg/day to the Carob-600 by oral gavage. The treatments were performed once daily until the first sign of puberty. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, total testosterone, leptin, glutathione, glutathione peroxidase (GPx), and malondialdehyde were measured by commercial rat-specific ELISA kits. Testis, uterus and ovarian tissue were examined histologically. Results: The median time of preputial separation in male rats was 38th, 31st, 31st, and 31st days in the Control, Carob-150, Carob-300, and Carob-600 groups, respectively (p=0.004). The median day of vaginal opening day was the 39th, 31st, 34th, and 31st days in the Control, Carob-150, Carob-300, and Carob-600 groups, respectively (p=0.059). FSH, LH, testosterone (male), estradiol (female) and leptin levels of the groups were similar. However, GPx levels were higher in male and female animals given C. siliqua extract compared to the Control (male p=0.001 and female p=0.008). Testicular and ovarian tissues were concordant with the pubertal period in all groups. As the dose of Ceratonia siliqua extract increased, it induced spermatogenesis and spermiogenesis, causing abnormal changes, such as ondulation in the basement membrane, capillary dilatation, and increased congestion in males. In females, edema in the medulla gradually increased with increased dosage, and granulosa cell connections were separated in Carob-300 and Carob-600 groups. Conclusion: This study demonstrated that C. siliqua caused early puberty and increased spermiogenesis and folliculogenesis. Antioxidant mechanisms were impaired with increasing dose, possibly leading to tissue damage at high doses.


Subject(s)
Fabaceae , Fruit , Female , Animals , Rats , Male , Humans , Leptin , Rats, Wistar , Plant Extracts/pharmacology , Puberty
2.
Turk J Med Sci ; 51(5): 2524-2533, 2021 10 21.
Article in English | MEDLINE | ID: mdl-34174792

ABSTRACT

Background/aim: The aim of this study was to investigate the effect of vitamin D on the disease prognosis and biochemical parameters in patients with mild obstructive sleep apnea syndrome (OSAS). Materials and methods: Nineteen adult male individuals (18­65 years) who were diagnosed with mild OSAS after polysomnography and had low vitamin D levels were included in the study. Each week, patients took 50.000 IU Vitamin D3 supplementation for 8 weeks. Polysomnography, biochemical parameters FBG (fasting blood glucose), lipid profile (TG, TC, LDL-C, HDL-C, VLDL-C), calcium, phosphorus, parathormone, calcitonin, serum 25(OH)D, insulin, CRP, TNF-α, IL-6, and IL-10 of patients were evaluated at the beginning of study and at the end of the study. All assessments, including polysomnography, were repeated after 8 weeks. Results: Serum vitamin D levels were initially 19.5 ± 5.01 ng/mL and increased to 41.8 ± 10.51 ng/mL (p < 0.001) at the end of the study. FBG, TC and HOMA-IR of the patients were significantly decreased (p < 0.05). CRP, TNF-α, IL-6, and IL-10 levels were also correlated with serum vitamin D levels (p < 0.05). There was a significant decrease in number of obstructive apneas, apneas a nd hypopneas, apnea index, hypopnea index, and apnea hypopnea index of the patients (p < 0.05). Conclusion: As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.


Subject(s)
Sleep Apnea, Obstructive/blood , Vitamin D/blood , Vitamins/blood , Adolescent , Adult , Aged , Dietary Supplements , Humans , Interleukin-10/blood , Interleukin-6/blood , Male , Middle Aged , Polysomnography , Prognosis , Sleep Apnea, Obstructive/diagnosis , Tumor Necrosis Factor-alpha/blood , Vitamin D/administration & dosage , Vitamin D/therapeutic use , Vitamins/administration & dosage , Vitamins/therapeutic use
3.
J Surg Res ; 263: 167-175, 2021 07.
Article in English | MEDLINE | ID: mdl-33667872

ABSTRACT

BACKGROUND: The capsular contracture is one of the main complications after radiotherapy in patients with implant-based reconstruction. The aim of this study is to evaluate the efficacy of ramipril for the prevention of radiation-induced fibrosis around the silicone implant. MATERIALS AND METHODS: Thirty Wistar rats in 5 groups were used. Group 1: implant; group 2: implant + radiation; group 3: ramipril + implant; group 4: ramipril + implant + radiation; group 5: sham. Ramipril treatment was started 5 d before surgery and continued for 12 wk after surgery. A mini silicone implant was placed in the back of the rats. A single fraction of 21.5 Gy radiation was applied. Tissues were examined histologically and immunohistochemically (TGF-ß1, MMP-2, and TIMP-2 expression). The alteration of plasma TGF-ß1 levels was examined before and after the experiment. RESULTS: After applying implant or implant + radiation, capsular thickness, percentage of fibrotic area, tissue and plasma TGF-ß1 levels significantly increased, and MMP-2/TIMP-2 ratio significantly decreased compared with the sham group. In ramipril-treated groups, the decrease in capsular thickness, fibrosis, TGF-ß1 positivity, and an increase in MMP-2/TIMP-2 ratio were found significant. In the ramipril + implant + radiation group, the alteration values of TGF-ß1 dramatically decreased. CONCLUSIONS: Our results show that ramipril reduces radiation-induced fibrosis and contracture. The results of our study may be important for the design of the clinical trials required to investigate the effective and safe doses of ramipril, which is an inexpensive and easily tolerated drug, on humans.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Breast/pathology , Implant Capsular Contracture/prevention & control , Radiation Injuries, Experimental/prevention & control , Ramipril/administration & dosage , Animals , Breast/radiation effects , Breast/surgery , Breast Implantation/adverse effects , Breast Implantation/instrumentation , Breast Implants/adverse effects , Breast Neoplasms/therapy , Female , Fibrosis , Humans , Implant Capsular Contracture/etiology , Implant Capsular Contracture/pathology , Male , Mastectomy/adverse effects , Radiation Injuries, Experimental/etiology , Radiation Injuries, Experimental/pathology , Radiotherapy, Adjuvant/adverse effects , Rats , Silicone Gels/adverse effects
4.
Arch Med Res ; 51(7): 664-669, 2020 10.
Article in English | MEDLINE | ID: mdl-32654881

ABSTRACT

AIM/BACKGROUND: Although many agents have been tested as treatment options for caustic esophageal burn (CEB), none have successfully suppressed the formation of strictures. Thus,the purpose of this study was to determine the efficacy of Contractubex® gel (10% onion extract, 50 U/gr heparin, and 1% allantoin) in stricture preventing after CEB. METHODS: In this study, 24 Wistar-albino rats were divided into 4 groups. CEB was initiated with an instillation of 1 mL of 10% NaOH solution into the an isolated esophageal segment for 3 min. Group C (control) was uninjured and untreated. In Group CEB, was initiated but no treatment was given. In Groups CTX1 and CTX2, the animals received 100 and 200 mg/kg/d, respectively, of Contractubex® for 4 weeks via gavage after CEB was initiated. The stenosis indices (SI), histopathologic damage scores, tissue hydroxyproline (HP) levels, and weights of the rats were taken before the experiment and 4 weeks after the experiment. RESULTS: The Mean SI levels, HP levels, and histopathologic damage scores were statistically lower in Groups CTX1 and CTX2 when compared with Group CEB (p <0.05). The treatment groups increased in weight when compared to Group CEB. The results were similar between Group CTX1 and Group CTX2 (p >0,05); the efficacy of the treatment was not dose-dependent. CONCLUSION: For the first time, Contractubex® was used for its antifibrotic, antioxidant, anti-inflammatory, and wound healing effects to treat caustic esophageal burn in rats. It was effective in reducing stricture formation by decreasing the HP levels and histopathologic damage as well as preventing stenosis and weight gain in the treatment groups.


Subject(s)
Allantoin/therapeutic use , Burns, Chemical/drug therapy , Constriction, Pathologic/drug therapy , Esophageal Stenosis/drug therapy , Heparin/therapeutic use , Plant Extracts/therapeutic use , Allantoin/pharmacology , Animals , Burns, Chemical/pathology , Disease Models, Animal , Drug Combinations , Heparin/pharmacology , Male , Plant Extracts/pharmacology , Rats , Rats, Wistar
5.
Food Chem Toxicol ; 109(Pt 1): 465-471, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28951307

ABSTRACT

High glucose and insulin lead to neuronal insulin resistance. Glucose transport into the neurons is achieved by regulatory induction of surface glucose transporter-3 (GLUT3) instead of the insulin. N-methyl-D aspartate (NMDA) receptor activity increases GLUT3 expression. This study explored whether an endogenous NMDA receptor antagonist, kynurenic acid (KynA) affects the neuronal cell viability at high glucose concentrations. SH-SY5Y neuroblastoma cells were exposed to 150-250 mg/dL glucose and 40 µU/mL insulin. In KynA and N-nitro-l-arginine methyl ester (L-NAME) supplemented cultures, oxidative stress, mitochondrial metabolic activity (MTT), nitric oxide as nitrite+nitrate (NOx) and GLUT3 were determined at the end of 24 and 48-h incubation periods. Viable cells were counted by trypan blue dye. High glucose-exposed SH-SY5Y cells showed two-times more GLUT3 expression at second 24-h period. While GLUT3-stimulated glucose transport and oxidative stress was increased, total mitochondrial metabolic activity was significantly reduced. Insulin supplementation to high glucose decreased NOx synthesis and GLUT3 levels, in contrast oxidative stress increased three-fold. KynA significantly reduced oxidative stress, and increased MTT by regulating NOx production and GLUT3 expression. KynA is a noteworthy compound, as an endogenous, specific NMDA receptor antagonist; it significantly reduces oxidative stress, while increasing cell viability at high glucose and insulin concentrations.


Subject(s)
Dopaminergic Neurons/metabolism , Glucose Transporter Type 3/metabolism , Glucose/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Biological Transport/drug effects , Cell Line , Cell Survival/drug effects , Dopaminergic Neurons/cytology , Dopaminergic Neurons/drug effects , Glucose Transporter Type 3/genetics , Humans , Insulin/metabolism , Kynurenic Acid/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Oxidative Stress/drug effects , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/genetics
6.
Turk Pediatri Ars ; 51(2): 94-9, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27489466

ABSTRACT

AIM: Lower respiratory tract infections including mainly pneumonia represent an important public health problem leading to high mortality and mobidity rates in children aged below five years in developing countries including our country. Vitamin D deficiency has been associated with increased risk of rickets/osteomalacia, various cancers, autoimmune diseases, hyperproliferative skin diseases, cardiovascular system diseases and infectious diseases. Vitamin D has an important role in cellular and humoral immunity and pulmonary functions. Vitamin D deficiency and lower respiratory tract infection are common health problems in children in our country and no clinical study investigating the relationship between these problems has been conducted so far. In this case-control study, we aimed to assess the association between vitamin D level and lower respiratory tract infection in children. MATERIAL AND METHODS: Sixty-three children aged between six months and five years with lower respiratory infections and 59 age-matched children who had no history of respiratory symptoms in the last month and no accompanying chronic disease were compared in terms of vitamin D levels. The children in the patient group were also evaluated by the clinical picture. RESULTS: No significant correlation was found between vitamin D levels and lower respiratory tract infection in terms of disease and its severity. However, it was found that vitamin D deficiency/ insufficiency was observed with a high rate in all children included in the study. CONCLUSIONS: Although no correlation was found between vitamin D level and lower respiratory tract infection, it is recommended that vitamin D level should be measured in children with lower respiratory tract infection and vitamin D supplementation should be given to all children especially in winter months based on the fact that the level of vitamin D was lower than normal in approximately half of the children included in the study and considering the effects of vitamin D on infections, pulmonary functions and immunity.

7.
J Matern Fetal Neonatal Med ; 28(15): 1799-802, 2015.
Article in English | MEDLINE | ID: mdl-25252637

ABSTRACT

OBJECTIVE: To compare interleukine-10 (IL-10) and total antioxidant capacity (TAC) levels after breast milk storage by studying premature and term mothers' colostrum and mature milk and by analyzing those levels relative to gestational week. METHODS: Fifty-four colostrum and mature breast milk samples were collected from both premature and term mothers. The samples were divided into three groups based on the time of analysis: fresh milk, at +4 °C for 72 h, and at -20 °C for 14 d. The IL-10 and TAC levels were measured quantitatively. RESULTS: Fresh colostrum and mature milk had similar IL-10 levels. Term mothers' fresh-colostrum TAC levels were higher than their mature milk. The mature milk of the premature mothers' had higher TAC levels than that of term mothers. Storage did not affect the IL-10 levels of breast milk, but fresh milk antioxidant capacity halved after 72 h and 14 d. Colostrum IL-10 and TAC levels did not correlate with gestational week. Mature milk IL-10 levels did not correlate with gestational week, but TAC levels negatively correlated with gestational week (r: -0.61: p < 0.01). CONCLUSIONS: The milk stored for 72 h at +4 °C and for 14 d at -20 °C did not maintain the same TAC levels as the fresh samples. This should be considered especially for sick infants who need more antioxidant capability in neonatal units.


Subject(s)
Antioxidants/analysis , Freezing , Interleukin-10/analysis , Milk, Human , Preservation, Biological/methods , Adult , Antioxidants/metabolism , Colostrum/chemistry , Colostrum/metabolism , Female , Humans , Infant, Newborn , Interleukin-10/metabolism , Milk, Human/chemistry , Milk, Human/metabolism , Pregnancy , Premature Birth/metabolism , Term Birth/metabolism , Young Adult
8.
Clin Toxicol (Phila) ; 50(6): 497-502, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22746384

ABSTRACT

INTRODUCTION: Carbon monoxide (CO) poisoning causes hypoxia that results tissue injury, especially in the brain and heart. Delayed neurologic sequela is one of the most serious complications that may occur up to 40% of severe CO poisoning cases. OBJECTIVE: The aim of the study was to determine an association between the serum tau protein and severe neurologic symptoms/signs upon presentation. METHODS: Seventy-eight patients with CO poisoning were evaluated in this cross-sectional study. The patients were divided into two groups, Group 1: those with loss of consciousness (LOC)/syncope, seizure, coma, altered mental status (n = 19), and Group 2; without LOC (n = 59). Serum tau protein levels were studied on admission. RESULTS: Mean age of the patients was 37.3 ± 15.4 and 53.6% were male. Headache was the most common presenting symptom observed among 67 patients (86%). The median serum tau protein level was 76.54 pg/mL (35.56-152.65) within group 1, 64.04 pg/mL (23.85-193.64) in patients within group 2 (p = 0.039), respectively. The median serum tau protein levels were 79.80 pg/mL (35.56-193.64) in patients who received HBO therapy and 65.79 pg/mL (23.85-167.29) in patients who did not receive HBO therapy (p = 0.032). The value of area under the curve was 0.642 for detecting CO poisoning with severe neurological symptoms. CONCLUSION: Although tau protein levels were significantly higher in patients with severe neurological symptoms; the difference did not reach a clinical significance. Further studies are needed in order to reveal the validity of tau protein for detecting neurological injuries in patients with CO toxicity.


Subject(s)
Carbon Monoxide Poisoning/blood , Nervous System Diseases/blood , tau Proteins/blood , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Hyperbaric Oxygenation , Male , Middle Aged , Prospective Studies
9.
World Neurosurg ; 73(6): 729-34, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20934165

ABSTRACT

BACKGROUND: Extensive research has focused on neuroprotection after spinal cord trauma to alleviate the effects of secondary injury. This study aims to investigate the neuroprotective effects of gabapentin in experimental spinal cord injury. METHODS: Thirty-six adult, male Wistar rats received spinal cord injury using the clip compression method. Animals were divided into five groups. High (200 mg/kg) and low doses (30 mg/kg) of gabapentin were administered to the animals in the treatment groups after spinal cord trauma and ultrastructural findings and lipid peroxidation levels of these two groups were compared with the animals that received only laminectomy, only trauma, and trauma and 30 mg/kg methylprednisolone. RESULTS: Regarding tissue lipid peroxidation levels after trauma, animals in gabapentin groups demonstrated better results than the trauma group. However, these results were no better than the methylprednisolone group. The results regarding the ultrastructural findings were similar. Treatment groups demonstrated better ultrastructural findings than the trauma group. In addition, the results of the high dose gabapentin group were significantly better than the low dose gabapentin group. CONCLUSIONS: Gabapentin demonstrated similar neuroprotective effects as methylprednisolone in early phase of spinal cord injury. Further studies with different experimental settings including neurological outcome are required to achieve conclusive results.


Subject(s)
Amines/pharmacology , Cyclohexanecarboxylic Acids/pharmacology , Neuroprotective Agents/pharmacology , Spinal Cord Injuries/drug therapy , gamma-Aminobutyric Acid/pharmacology , Amines/therapeutic use , Animals , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/therapeutic use , Calcium Channels, L-Type/drug effects , Calcium Channels, L-Type/physiology , Cyclohexanecarboxylic Acids/therapeutic use , Disease Models, Animal , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Amino Acid Antagonists/therapeutic use , GABA Agonists/pharmacology , GABA Agonists/therapeutic use , Gabapentin , Male , Neuroprotective Agents/therapeutic use , Random Allocation , Rats , Rats, Wistar , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Treatment Outcome , gamma-Aminobutyric Acid/therapeutic use
10.
Pediatr Dermatol ; 27(5): 534-5, 2010.
Article in English | MEDLINE | ID: mdl-20807356

ABSTRACT

Acrodermatitis enteropathica is a rare and distinct form of zinc deficiency with a requirement of life-long zinc supplementation and inherited in a recessive manner. Transient nutritional zinc deficiency is also a well known condition mimicking acrodermatitis enteropathica like skin changes in preterm and term infants who are generally breastfed with a low level of zinc containing milk. Here, a 4-month-old male, term and fully breastfed acrodermatitis enteropathica case without hypozincemia and with maternal milk of low zinc level is presented.


Subject(s)
Breast Feeding/adverse effects , Milk, Human/metabolism , Zinc/blood , Zinc/deficiency , Acrodermatitis/blood , Acrodermatitis/etiology , Acrodermatitis/pathology , Humans , Infant , Male , Skin/pathology
11.
Pediatr Neurol ; 39(4): 266-71, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18805365

ABSTRACT

This study evaluated the effects of oxcarbazepine monotherapy on bone turnover in prepubertal and pubertal children. Thirty-four newly diagnosed pediatric patients with normal bone mineral density, serum biochemical markers of bone formation, and hormonal markers participated. Levels of 25-hydroxyvitamin D were significantly decreased after therapy compared with baseline values. Levels of gamma-glutamyl transferase, phosphorus, alkaline phosphatase, osteocalcin, parathyroid hormone, and calcitonin had increased. However, only changes in osteocalcin and gamma-glutamyl transferase levels were statistically significant compared with baseline values. Drug-induced osteopenia was evident in 3 patients with z scores of bone-mineral density less than -2.0, whereas these patients had z scores of less than -1.5 before treatment. Although 18 months of oxcarbazepine treatment exerted slightly adverse effects on bone metabolism, the effect seems insignificant in children with normal bone-mineral density. Although alterations in bone metabolism do not always suffice to explain the decrease in bone-mineral metabolism, we think that patients with osteopenia before the initiation of oxcarbazepine therapy should be followed carefully, especially in long-term treatment.


Subject(s)
Bone Density/drug effects , Bone Diseases, Metabolic/chemically induced , Carbamazepine/analogs & derivatives , Osteogenesis/drug effects , Administration, Oral , Adolescent , Alkaline Phosphatase/blood , Anticonvulsants/administration & dosage , Anticonvulsants/adverse effects , Anticonvulsants/therapeutic use , Biomarkers/blood , Bone Diseases, Metabolic/metabolism , Calcitonin/blood , Carbamazepine/administration & dosage , Carbamazepine/adverse effects , Carbamazepine/therapeutic use , Child , Epilepsy , Humans , Osteocalcin/blood , Oxcarbazepine , Parathyroid Hormone/blood , Phosphorus/blood , Vitamin D/analogs & derivatives , Vitamin D/blood , gamma-Glutamylcyclotransferase/blood
SELECTION OF CITATIONS
SEARCH DETAIL